Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Flatiron

- PMLiVE

Sanofi and Regeneron’s Dupixent granted FDA priority review for bullous pemphigoid

Approximately 27,000 adults in the US are living with uncontrolled cases of the skin disease

- PMLiVE

Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading

The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...

Petauri Evidence

EU flag

EC approves Galderma’s Nemluvio to treat atopic dermatitis and prurigo nodularis

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha

- PMLiVE

FDA approves Bavarian Nordic’s chikungunya vaccine for individuals aged from 12 years

The mosquito-borne viral disease has been reported across many popular travel destinations

- PMLiVE

GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval

It is hoped that the combination vaccine will simplify delivery and lead to higher uptake

- PMLiVE

Roche’s Evrysdi tablet formulation granted FDA approval for spinal muscular atrophy

The progressive neuromuscular disease affects approximately one in every 10,000 babies globally

- PMLiVE

Pfizer granted FDA approval for Adcetris combination in large B-cell lymphoma

Up to 70% of patients with this form of non-Hodgkin lymphoma are diagnosed with advanced disease

- PMLiVE

FDA approves SpringWorks Therapeutics’ Gomekli to treat neurofibromatosis type 1

The rare genetic disorder affects approximately 100,000 people in the US

- PMLiVE

AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections

Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

- PMLiVE

FDA approves Supernus Pharmaceuticals’ Onapgo to treat advanced Parkinson’s disease

The neurodegenerative disorder affects almost one million people in the US

- PMLiVE

Pfizer announces positive phase 3 results for Braftovi regimen in colorectal cancer

An estimated 154,270 people will be diagnosed with cancer of the colon or rectum in the US this year

Biogen Idec building

Biogen’s higher dose spinal muscular atrophy regimen accepted for review by EMA/FDA

The neuromuscular disease affects approximately one in every 10,000 babies worldwide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links